Finland
· Delayed Price · Currency is EUR Nightingale Health Oyj Statistics
Total Valuation
HEL:HEALTH has a market cap or net worth of EUR 172.00 million. The enterprise value is 113.99 million.
| Market Cap | 172.00M |
| Enterprise Value | 113.99M |
Important Dates
The next estimated earnings date is Wednesday, June 4, 2025.
| Earnings Date | Jun 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEL:HEALTH has 60.35 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 60.35M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +1.93% |
| Owned by Insiders (%) | 28.24% |
| Owned by Institutions (%) | 7.59% |
| Float | 34.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.74 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.65 |
| EV / Sales | 23.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.52 |
Financial Position
The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.46 |
| Quick Ratio | 12.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.17 |
| Interest Coverage | -55.73 |
Financial Efficiency
Return on equity (ROE) is -20.65% and return on invested capital (ROIC) is -13.43%.
| Return on Equity (ROE) | -20.65% |
| Return on Assets (ROA) | -12.91% |
| Return on Invested Capital (ROIC) | -13.43% |
| Return on Capital Employed (ROCE) | -24.20% |
| Revenue Per Employee | 52,670 |
| Profits Per Employee | -182,298 |
| Employee Count | 86 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.71% in the last 52 weeks. The beta is 0.60, so HEL:HEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +64.71% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 2.92 |
| Relative Strength Index (RSI) | 47.93 |
| Average Volume (20 Days) | 40,109 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HEL:HEALTH had revenue of EUR 4.95 million and -17.14 million in losses. Loss per share was -0.28.
| Revenue | 4.95M |
| Gross Profit | 3.60M |
| Operating Income | -18.39M |
| Pretax Income | -17.07M |
| Net Income | -17.14M |
| EBITDA | -15.28M |
| EBIT | -18.39M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 59.71 million in cash and 1.70 million in debt, giving a net cash position of 58.01 million or 0.96 per share.
| Cash & Cash Equivalents | 59.71M |
| Total Debt | 1.70M |
| Net Cash | 58.01M |
| Net Cash Per Share | 0.96 |
| Equity (Book Value) | 75.66M |
| Book Value Per Share | 1.25 |
| Working Capital | 57.08M |
Cash Flow
In the last 12 months, operating cash flow was -8.36 million and capital expenditures -1.54 million, giving a free cash flow of -9.90 million.
| Operating Cash Flow | -8.36M |
| Capital Expenditures | -1.54M |
| Free Cash Flow | -9.90M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | 72.77% |
| Operating Margin | -371.46% |
| Pretax Margin | -344.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEL:HEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -9.96% |
| FCF Yield | -5.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HEL:HEALTH has an Altman Z-Score of 13.67.
| Altman Z-Score | 13.67 |
| Piotroski F-Score | n/a |